Jay T. Backstrom

Companies

• Agios PharmaceuticalsBoard member Jul 10, 2025 to now¹
• LAVA Therapeutics NVBoard member Jan 2, 2025 to now²
• Scholar Rock Holding CorpBoard member Feb 13, 2024 to Mar 12, 2025³
• Scholar Rock Holding CorpChief executive officer Sep 22, 2022 to Mar 12, 2025⁴
• Disc Medicine, Inc.Board member Jan 3, 2023 to Jan 3, 2023⁵
• Acceleron PharmaEVP, Research and Development Dec 17, 2019 to Nov 22, 2021⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SRScholar Rock Holding Corp SRRK425,561 shares⁷$17.4M at $40.78Mar 10, 2025
• Agios Pharmaceuticals AGIO1,447 shares⁸$49.7K at $34.36Jul 8, 2026
• APAcceleron Pharma XLRN0 shares⁹Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 8, 2026Granted 1,447 shares of Agios Pharmaceuticals⁸
• Mar 10, 2025Granted 113,570 shares of Scholar Rock Holding Corp⁷
• Feb 18, 2025Sold 18,372 shares at $36.83 of Scholar Rock Holding Corp¹⁰
• Jan 16, 2025Sold 22,308 shares at $44.20 of Scholar Rock Holding Corp¹¹
• Feb 16, 2024Sold 11,614 shares at $15.74 of Scholar Rock Holding Corp¹²
• Feb 12, 2024Granted 214,285 shares of Scholar Rock Holding Corp¹³
• Feb 13, 2023Granted 150,000 shares of Scholar Rock Holding Corp¹⁴
• Nov 19, 2021U 21,233 shares of Acceleron Pharma⁹